"There seems to be a broad range of sensitivity to the medications among different people." In practical terms, that means a lower dose may still help with appetite, food noise and weight loss but results may be slower, less predictable or insufficient compared with the regimens that have actually been studied
Causes and Management GLP-1 receptor agonists are widely prescribed in the UK for type 2 diabetes and weight management
Drug interactions and safety
For instance, exenatide, the first GLP-1-analogue developed, demonstrated to promote human monocyte differentiation into alternatively activated M2 macrophages, leading to an increase in anti-inflammatory cytokines such as IL-10 while significantly reducing pro-inflammatory cytokines, including IL-6, TNF- and IL-1 (43)
A BMI of 27 or higher (considered overweight) and at least one weight-related health condition, such as high blood pressure, diabetes, or high cholesterol
At this time, however, these conclusions are limited to speculation given the nature of a single case report